ArticleACS omega2025
An Efficient Strategy to Boost the Removal Efficiency for Submicron Particles and VOCs of Polypropylene in the Complex Flue Gas.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Particulate matter (PM) is recognized as a significant environmental risk factor, with profound adverse effects on human health. The development of air filters that maintain high performance under complex environmental conditions remains a challenge. Herein, a novel composite air filter was fabricated by the in situ growth of ZIF-8 nanoparticles onto polypropylene (PP) fibers in this study, aiming to enhance filtration efficiency and adaptability in challenging environments. The results demonstrated that the PP/ZIF-8 membrane contained a substantial number of rhombic dodecahedron crystals. The removal efficiencies could be obtained at 84.6%, 92.6%, 93.5%, 95.8%, and 96.9% for PM
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.